When directly looking at the specific cytokines found to be able to predict the NfL levels (CRP, IL-4, IL-8, IL-9, Eotaxin, and MIP-1ß), the literature highlight that all the selected factors are highly up-regulated during COVID-19 and associated with clinical outcomes. The gene discussed is NEFL; the disease is COVID-19.